Business and Finance

ARM-sponsored study projects a 23% reduction in the cost of treating blood diseases in 2029 by administering cellular and genetic therapies

Trump administration drops its bombshell proposal to open up the US pharmaceutical market

The ‘broken promise’ of lower-cost insulin, according to Senators Warren and Blumenthal

Higher inventory turns, lower inventories—but lower profit margins, too

Change.org touts its influence in the decision

Dealing with pharma’s commercial data deluge

Licensing for Gilead’s Truvada and Descovy products is in question

Action expands Pharma Logistics’ leadership in servicing independent pharmacies

Task force report highlights the economic disincentives of short-supply products

Upstart organization seeks to create another pathway for acceptance by regulators and pharmacy benefit managers

Analysis of its members’ covered lives show the effect of expensive specialty drugs on insurance plans

Leading pharma sampling-services company ‘recapitalizes’ with acquisition by Court Square Capital

The trend line, which had been downward for nearly a decade, is turning

KPMG survey finds higher interest in M&A, but not as the top choice

Building up a service offering from the research lab to the patient’s home

RACollab.org invites trade and channel execs to participate

HHS Azar announces a plan to make a plan, roughly in time to be a talking point in next year’s national election

Increase of 3.8% over 2018; drug costs up 2.1%

2019 survey results characterize the field by job, managment level and location

HDA Research Foundation highlights constraints and additional costs of reimportation

News follows court ruling against advertising retail drug prices

Business Intelligence meets Big Data

A hospital-led supply consortium is only just getting started